2026 Zoltán Szekanecz: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	84	1375	1253	1	1	513	25491
Medicine	84	15110	14220	5	5	534	25593

Zoltán Szekanecz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Zoltán Szekanecz sits on this spectrum.

62 publications 807+

This scientist: 513 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Zoltán Szekanecz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Zoltán Szekanecz sits on this spectrum.

40 D-Index 157+

This scientist: 84 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

2026 - Research.com Immunology in Hungary Leader Award
2025 - Research.com Immunology in Hungary Leader Award
2023 - Research.com Immunology in Hungary Leader Award
2022 - Research.com Immunology in Hungary Leader Award
2020 - Member of Academia Europaea

Overview

Zoltán Szekanecz is affiliated with the University of Debrecen in Hungary. Their research primarily focuses on the field of Medicine, with significant contributions specifically in Rheumatology, Infectious Diseases, Immunology, Pathology and Forensic Medicine, and Oncology.

The scientist's work covers several main topics, including:

Rheumatoid Arthritis Research and Therapies
Systemic Lupus Erythematosus Research
Spondyloarthritis Studies and Treatments
COVID-19 Clinical Research Studies
SARS-CoV-2 and COVID-19 Research
Autoimmune and Inflammatory Disorders Research
Systemic Sclerosis and Related Diseases

Selected recent papers authored or coauthored by Szekanecz include:

"EULAR definition of difficult-to-treat rheumatoid arthritis," 2020, Annals of the Rheumatic Diseases
"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome," 2022, Annals of the Rheumatic Diseases
"EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis," 2021, Annals of the Rheumatic Diseases
"Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases," 2021, Nature Reviews Rheumatology
"Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance," 2022, Annals of the Rheumatic Diseases

The scientist frequently publishes in several venues, predominantly:

Annals of the Rheumatic Diseases
Orvosi Hetilap
Frontiers in Medicine
Nature Reviews Rheumatology
RMD Open

Collaborations are an important part of their research, with frequent coauthors including Gabriella Szűcs, Szilvia Szamosi, Katalin Hodosi, Attila Hamar, and György Kerekes. These partnerships reflect ongoing collaborative efforts in rheumatology and related medical fields.

In 2020, Zoltán Szekanecz was recognized as a Member of Academia Europaea, reflecting their standing in the scientific community.

Best Publications

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

M J Peters;D P M Symmons;D McCarey;B A Dijkmans

2125
Citations
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

R. Agca;S. C. Heslinga;S. Rollefstad;M. Heslinga

1484
Citations
2016 update of the EULAR recommendations for the management of early arthritis

Bernard Combe;Robert Landewe;Claire I Daien;Charlotte Hua

679
Citations
2018 update of the EULAR recommendations for the management of hand osteoarthritis

Margreet Kloppenburg;Féline P.B. Kroon;Francisco J. Blanco;Michael Doherty

519
Citations
EULAR definition of difficult-to-treat rheumatoid arthritis

György Nagy;Nadia Mt Roodenrijs;Paco Mj Welsing;Melinda Kedves

489
Citations
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

Unknown

447
Citations
Vitamin D and autoimmune thyroid diseases

Shaye Kivity;Nancy Agmon-Levin;Michael Zisappl;Yinon Shapira

442
Citations
Genetics of rheumatoid arthritis - A comprehensive review

Júlia Kurkó;Timea Besenyei;Judit Laki;Tibor T. Glant

440
Citations
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?

H. Amital;Z. Szekanecz;G. Szücs;K. Dankó

389
Citations
Macrophages and their products in rheumatoid arthritis.

Zoltán Szekanecz;Alisa E Koch;Alisa E Koch

385
Citations
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

Ernest Choy;Kandeepan Ganeshalingam;Anne Grete Semb;Zoltán Szekanecz

366
Citations
Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases.

Hedi Orbach;Gisele Zandman-Goddard;Gisele Zandman-Goddard;Howard Amital;Howard Amital;Vivian Barak

347
Citations
Chemokines and chemokine receptors in rheumatoid arthritis.

Zoltán Szekanecz;Joon Kim;Alisa E Koch

319
Citations
Association of systemic and thyroid autoimmune diseases.

Edit Biró;Zoltán Szekanecz;László Czirják;Katalin Dankó

282
Citations
Mechanisms of Disease: angiogenesis in inflammatory diseases.

Zoltán Szekanecz;Alisa E Koch

268
Citations
Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis.

Péter Szodoray;Zoltán Szabó;Anikó Kapitány;Ágnes Gyetvai

255
Citations
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

Unknown

251
Citations
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis.

György Nagy;Nadia M T Roodenrijs;Paco M J Welsing;Melinda Kedves

250
Citations
Vascular involvement in rheumatic diseases: 'vascular rheumatology'

Zoltán Szekanecz;Alisa E Koch;Alisa E Koch

244
Citations
Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.

György Kerekes;Zoltán Szekanecz;Henriett Dér;Zsuzsa Sándor

243
Citations
In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease.

A E Koch;L B Kronfeld-Harrington;Z Szekanecz;M M Cho

225
Citations
Rheumatoid arthritis and metabolic syndrome

György Kerekes;Michael T. Nurmohamed;Miguel A. González-Gay;Ildikó Seres

220
Citations
Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis.

Zoltan Szekanecz;Margaret M. Halloran;Michael V. Volin;James M. Woods

216
Citations

Frequent Co-Authors

Alisa E. Koch University of Michigan–Ann Arbor

Gyula Szegedi University of Debrecen

Peter Szodoray Oslo University Hospital

Yehuda Shoenfeld Sheba Medical Center

Gabriella Lakos Thermo Fisher Scientific (United States)

Emese Kiss Semmelweis University

Margit Zeher University of Debrecen

Katalin Mikecz Rush University Medical Center

Laszlo Nagy University of Debrecen

Tibor T. Glant Rush University Medical Center

External Links

Personal website of Zoltán Szekanecz

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Studying immunology opens diverse career pathways in healthcare and research. Many students interested in clinical applications explore nursing degrees to gain practical skills alongside their scientific knowledge. For those without a nursing background, 12-month accelerated nursing programs online for non nurses offer a fast and flexible route to enter this field.

If you want to start nursing studies quickly, looking into the easiest accelerated nursing programs can simplify admissions and shorten the path to becoming a registered nurse. Additionally, for roles focused on direct patient care, programs like lpn schools easy to get into provide accessible options as a Licensed Practical Nurse.

Advanced practice nurses with specialized knowledge can explore easiest np program options to become Nurse Practitioners, enhancing their scope of practice in immunology-related healthcare settings.

Combining immunology with nursing expertise can lead to impactful roles in patient care, public health, and biomedical research. Choosing the right degree depends on your current qualifications, career goals, and the level of clinical involvement desired.